VC Deals Biotechnology
Google News : U.S. : All
- Silicon Valley’s share of venture capital expected to drop below 20% for the first time this year - CNBC
- End of Year Update: 2020 Life Science Venture Capital Funding Roundup in the BioHealth Capital Region - BioBuzz
- Strong 2020 Leaves Biotech Venture Capitalists Upbeat for New Year - The Wall Street Journal
- Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body - GeekWire
- Private markets: Biotech funds point to the future - Funds Europe Magazine
- Venture capital found its footing in biotech. Then came the virus. - BioPharma Dive
- Temasek-Backed Chinese Cancer Biotech Firm Gracell Files for $100 Million US IPO - Caixin Global
- Sana Bio's $150 Million IPO Expected to Provide Market Valuation of $10 Billion - BioSpace
- Korean venture capital E& leads merger of clinical stage biotech firms - The Investor
- European Biotech Venture Capital Fundraising Surges as 2020 Closes - Labiotech.eu
- Biotechnology draws $12.6B from private equity, venture capital activity in H1 - S&P Global
- With biotech funding at 'all-time high,' Scorpion scoops up $162 million - STAT
- Nasdaq rings in its first biotech IPOs of 2021: a CAR-T specialist from China, a cancer portfolio play, and a SPAC - Endpoints News
- Biotech, pharma investments on VC radar in 2021 - PitchBook - Reuters
- US and Chinese startup investments swell amid pandemic - Nikkei Asia
